The Clinical trials support services market is estimated to be valued at US$ 22.38 Bn in 2023 and is expected to exhibit a CAGR of 7.5% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
Clinical trials support services include a variety of services provided throughout the clinical trial process from feasibility to closeout. These services include clinical trial design and management, regulatory support, medical writing, patient recruitment, site management, data management, and statistics. They help pharmaceutical and biotechnology companies conduct clinical trials in a timely and cost-effective manner. Some key use cases include supporting pharmaceutical companies in drug development by planning and executing clinical trials, patient recruitment and retention services, and ensuring compliance with regulatory guidelines.

Market Dynamics:
The high growth of the clinical trials support services market can be attributed to the rising outsourcing of clinical trials by pharmaceutical companies. The clinical trial process is costly, complex, and time-consuming requiring specialized resources. Therefore, many pharmaceutical companies prefer outsourcing various clinical trial functions such as patient recruitment and retention, data management, and regulatory affairs to clinical research organizations (CROs) and other clinical trial support service providers. This helps them focus on drug innovation while saving costs. Moreover, the increasing R&D expenditure by biopharmaceutical companies for developing novel drugs is also driving the demand for external clinical trial support. Furthermore, a growing number of CROs providing specialized clinical trial services coupled with rising clinical trial activities in emerging countries are poised to present lucrative growth opportunities over the forecast period.

SWOT Analysis

Strength: The clinical trials support services market has gained immense popularity over the past few years due to high demand from pharma and biotech companies. Presence of several full service contract research organizations offers end-to-end support from protocol development to study report submission. Furthermore, advanced technologies such as electronic data capture systems and electronic patient reported outcomes have increased efficiency of clinical trials.

Weakness: High costs associated with clinical trials can be a major hindrance, especially for small companies. Lack of skilled professionals in developing regions poses challenges in patient recruitment and data management.

Opportunity: Growth of outsourcing trend among pharma firms facilitates market growth. Increase in R&D expenditure for development of new drugs and devices presents lucrative opportunities. Furthermore, rising disease prevalence has accelerated clinical trial activities worldwide.

Threats: Stringent regulations delay drug approval process and increase complexity of clinical trials. Poor infrastructure in developing nations affects patient enrollment. Emergence of alternate drug development pathway such as real world evidence also poses threats.

Key Takeaways 

The global Clinical Trials Support Services Market is expected to witness high growth, exhibiting a CAGR of 7.5% over the forecast period of 2023-2030, due to increasing R&D expenditure by pharmaceutical companies and rising complexities in drug development. The market was valued at US$ 22.38 billion in 2023.

Regional analysis: North America currently dominates the global market attributed to presence of major pharmaceutical companies and clinical research organizations in the region. Asia Pacific is poised to be the fastest growing market owing to low-cost advantages and increasing patient population. Countries like China and India offer lucrative opportunities for clinical trial outsourcing.

Key players: Key players operating in the clinical trials support services market are Wuxi AppTec, Inc., IQVIA Holdings, Inc., Syneos Health, Inc., Eurofins Scientific, Laboratory Corporation of America Holdings (Labcorp), Icon PLC, ALCURA, Parexel International Corporation, PPD, Inc. (Pharmaceutical Product Development), and Charles River Laboratories International, Inc. These players are focusing on new service launches and partnerships to consolidate their market position.

 

Read More: https://webinsightworld.blogspot.com/2023/12/clinical-trial-recruitment-is-fastest.html